AR105066A1 - ENZYMES AND CRISPR SYSTEMS - Google Patents

ENZYMES AND CRISPR SYSTEMS

Info

Publication number
AR105066A1
AR105066A1 ARP160101833A ARP160101833A AR105066A1 AR 105066 A1 AR105066 A1 AR 105066A1 AR P160101833 A ARP160101833 A AR P160101833A AR P160101833 A ARP160101833 A AR P160101833A AR 105066 A1 AR105066 A1 AR 105066A1
Authority
AR
Argentina
Prior art keywords
methods
targeting
systems
enzymes
crispr systems
Prior art date
Application number
ARP160101833A
Other languages
Spanish (es)
Inventor
Slaymaker Ian
O Abudayyeh Omar
Gootenberg Jonathan
Zetsche Bernd
Zhang Feng
Original Assignee
Broad Inst Inc
Massachusetts Inst Technology
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Broad Inst Inc, Massachusetts Inst Technology, Harvard College filed Critical Broad Inst Inc
Publication of AR105066A1 publication Critical patent/AR105066A1/en

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

Sistemas, métodos y composiciones para el direccionamiento de ácidos nucleicos. En particular, provee sistemas de direccionamiento de ADN no natural o manipulado que comprende una proteína efectora CRISPR de, direccionamiento de ADN o ARN y por lo menos un componente de ácido nucleico de direccionamiento tal como un ARN guía. También se divulgan y reivindican métodos para elaborar y utilizar, y los usos, de dichos sistemas, métodos y composiciones, y productos de dichos métodos y usos.Systems, methods and compositions for nucleic acid targeting. In particular, it provides non-natural or manipulated DNA targeting systems comprising a CRISPR effector protein, DNA or RNA targeting and at least one targeting nucleic acid component such as a guide RNA. Methods for making and using, and the uses, of said systems, methods and compositions, and products of said methods and uses are also disclosed and claimed.

ARP160101833A 2015-06-18 2016-06-21 ENZYMES AND CRISPR SYSTEMS AR105066A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562181739P 2015-06-18 2015-06-18

Publications (1)

Publication Number Publication Date
AR105066A1 true AR105066A1 (en) 2017-09-06

Family

ID=59981588

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160101833A AR105066A1 (en) 2015-06-18 2016-06-21 ENZYMES AND CRISPR SYSTEMS

Country Status (1)

Country Link
AR (1) AR105066A1 (en)

Similar Documents

Publication Publication Date Title
MX2020011939A (en) Novel crispr enzymes and systems.
CY1120520T1 (en) NUCLEAR-mediated DNA Assemblage
CO2017011957A2 (en) Alpha-amylase variants and polynucleotides encoding the same
AU2018251801A8 (en) Novel type VI CRISPR orthologs and systems
WO2016205749A8 (en) Novel crispr enzymes and systems
EA201890012A1 (en) METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF INFECTION CAUSED BY HIV
BR112018013930A2 (en) oncolytic virus, virus expressing three heterologous genes, pharmaceutical composition, virus for use, manufacturing product, cancer treatment method, and virus use
WO2017127807A8 (en) Crystal structure of crispr cpf1
SG10201805815YA (en) Rna-guided gene drives
MX2018005392A (en) Engineered nucleic-acid targeting nucleic acids.
MX2017004039A (en) Galnac phosphoramidites, nucleic acid conjugates thereof and their use.
EA201691581A1 (en) METHODS AND COMPOSITIONS FOR IMPROVING THE EFFICIENCY OF DIRECTED MODIFICATION OF GENES WITH THE APPLICATION OF MEDIATED OLIGONUCLEOTIDE REPAIR GENES
CO2019003846A2 (en) Aav treatment of huntington's disease
BR112016016916A2 (en) hereditary angiodema treatment method (hae)
BR112019000693A2 (en) mucocharge compositions and methods for use
AR103226A1 (en) HAPLOID INDUCTOR
CO2018007568A2 (en) Compositions and methods for efficient transgene addressing
EP3283630A4 (en) Oligonucleotide fragment, and method as well as application of selective amplifiction of variant of target nucleic acid sequence using the same
CO2021012310A2 (en) Compositions and methods for treating laminopathies
CY1120997T1 (en) UTI Fusion PROTEINS
CO2017011617A2 (en) Nucleoside agents for reducing the harmful activity of genes that contain extended nucleotide repeats
CO2017009163A2 (en) RNA polymerase ii33 nucleic acid molecules for insect pest control
MX2018005872A (en) Nucleic acid prodrugs.
CL2022001481A1 (en) Nucleic acid compositions
AR102061A1 (en) CHROMOBACTERIUM SUBTSUGAE GENES